A key message in our Sustainable Immunization Financing (SIF) Program work is that countries need to reduce their dependencies by appropriating their routine immunization programs.

The 9th International Rotavirus Symposium brought together 365 participants from 65 countries from August 2-3, 2010 in Johannesburg, South Africa.

By Stephanie Bricking, Albert B. Sabin Archivist, University of Cincinnati

In partnership with the Fraunhofer Center for Molecular Biotechnology and the Walter Reid Army Institute for Research, the Sabin Vaccine Institute has successfully expressed the hookworm-derived antigen Na-APR-1.

The Sabin Sustainable Immunization Financing (SIF) Program was on the agenda at a symposium hosted by the Penn Center for Vaccine Ethics and Policy.

A new study asserts that a particular type of schistosomiasis may predispose women to contracting HIV.

Late last month ONE launched a new campaign to increase funding for two new vaccines for pneumococcal and diarrheal diseases. The campaign video features kids asking “why bother?”

By Jacqueline Mills

Dr. Peter Hotez, Sabin’s President, recently authored an op-ed in The Hinducalling on a new modern India to “invest in neglected tropical disease (NTD) elimination efforts--including the development of drugs, diagnostics, and vaccines--that will reduce the large NTD burden in South Asia.”

Pages